Alan Pollack

Also affiliated with Sylvester Comprehensive Cancer Center

MedicinePhysics and Astronomy

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile

0.489Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Transcriptome profiling of NRG Oncology/RTOG 9601: Validation of a prognostic genomic classifier in salvage radiotherapy prostate cancer patients from a prospective randomized trial.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.276

Top 39%

0.489DataRank

Top 39%11 citations

Howard M. Sandler, Huei–Chung Huang, Jeffry Simko, Elai Davicioni, Paul L. Nguyen +15 more

Papers

Driven by 24 papers — median percentile 61. Top paper: “Analysis of a Biopsy-Based Genomic Classifier in High-Risk Prostate Cancer: Meta-Analysis of the NRG Oncology/Radiation Therapy Oncology Group 9202, 9413, and 9902 Phase 3 Randomized Trials”.

Analysis of a Biopsy-Based Genomic Classifier in High-Risk Prostate Cancer: Meta-Analysis of the NRG Oncology/Radiation Therapy Oncology Group 9202, 9413, and 9902 Phase 3 Randomized Trials

International Journal of Radiation Oncology*Biology*Physics(2022)10.1016/j.ijrobp.2022.12.035

N/A

1.1DataRank · unranked

51 citations

Huei–Chung Huang, Daniel E. Spratt, Elai Davicioni, Howard M. Sandler, William U. Shipley +17 more

Transcriptome profiling of NRG Oncology/RTOG 9601: Validation of a prognostic genomic classifier in salvage radiotherapy prostate cancer patients from a prospective randomized trial.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.276

Top 39%

0.489DataRank

Top 39%11 citations

Howard M. Sandler, Huei–Chung Huang, Jeffry Simko, Elai Davicioni, Paul L. Nguyen +15 more

Transcriptomic Analysis of Localized High-risk Prostate Cancer Improves Prognostication and Identifies Benefit from Adding Docetaxel to Definitive Radiotherapy with Androgen Suppression in the NRG Oncology/RTOG 0521 Phase 3 Trial

European Urology Oncology(2025)10.1016/j.euo.2025.04.009

N/A

0.214DataRank · unranked

3 citations

James A. Proudfoot, Elai Davicioni, Yang Liu, Daniel E. Spratt, Jeffry Simko +17 more

HRS Improves Active Surveillance for Prostate Cancer by Timely Identification of Progression

Academic Radiology(2024)10.1016/j.acra.2024.11.008

N/A

0.165DataRank · unranked

2 citations

Veronica Wallaengen, Evangelia I. Zacharaki, Adrian Breto, Ahmad Algohary, Sophia Carbohn +14 more

SMPDL3b modulates radiation‐induced DNA damage response in renal podocytes

The FASEB Journal(2022)10.1096/fj.202100186rr

N/A

0DataRank · unranked

15 citations

Anis Ahmad, Larry Bodgi, Patrick Azzam, Tarek Youssef, Alaa Abou Daher +6 more

Long-Term Results of a Phase 3 Randomized Prospective Trial of Erectile Tissue-Sparing Intensity-Modulated Radiation Therapy for Men With Clinically Localized Prostate Cancer

International Journal of Radiation Oncology*Biology*Physics(2022)10.1016/j.ijrobp.2022.12.008

N/A

0DataRank · unranked

16 citations

Karen Ruth, Mark K. Buyyounouski, R Price, Robert G. Uzzo, Mark L. Sobczak +9 more

Radiation nephropathy: Mechanisms of injury and recovery in a murine model

Radiotherapy and Oncology(2023)10.1016/j.radonc.2023.109813

N/A

0DataRank · unranked

8 citations

Junwei Shi, Saba Ansari, Sandra Merscher, Alan Pollack, Youssef H. Zeidan +3 more

Basal-luminal subtyping of localized high-risk prostate cancer and benefit of adding docetaxel to definitive radiotherapy with androgen suppression in the NRG Oncology/RTOG 0521 phase III trial.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5094

N/A

0DataRank · unranked

3 citations

James A. Proudfoot, Elai Davicioni, Yang Liu, Daniel E. Spratt, Felix Y. Feng +15 more

Radiogenomic profiling of prostate tumors prior to external beam radiotherapy converges on a transcriptomic signature of TGF-β activity driving tumor recurrence

The Medicine Forum(2023)10.1101/2023.05.01.23288883

N/A

0DataRank · unranked

0 citations

Uma Shankavaram, Shana Y. Trostel, Hong Zhang, Houssein Abdul Sater, Stephanie A. Harmon +12 more

Neurocognitive function outcomes in NRG/RTOG 0534, the SPPORT trial.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.12022

N/A

0DataRank · unranked

0 citations

Theodore Karrison, Alan Pollack, Alexander G. Balogh, Deborah Watkins Bruner, Leonard G. Gomella +14 more

Radiation-Induced Nephrotoxicity: Role of Sphingomyelin Phosphodiesterase Acid-like 3b

International Journal of Radiation Oncology*Biology*Physics(2024)10.1016/j.ijrobp.2024.11.105

N/A

0DataRank · unranked

3 citations

Shamroop Kumar Mallela, Saba Ansari, Mohammed Alnukhali, Misha Ali, Merscher Sandra +5 more

Biopsy-based Basal-luminal Subtyping Classifier in High-risk Prostate Cancer: A Combined Analysis of the NRG Oncology/RTOG 9202, 9413, and 9902 Phase 3 Trials

European Urology Oncology(2024)10.1016/j.euo.2024.10.017

N/A

0DataRank · unranked

2 citations

Paul L. Nguyen, James A. Proudfoot, Yang Liu, Alan Dal Pra, Daniel E. Spratt +16 more

Assessing the Molecular Heterogeneity of Prostate Cancer Biopsy Sampling: Insights from the MAST Trial

European Urology Focus(2024)10.1016/j.euf.2024.11.012

N/A

0DataRank · unranked

3 citations

Hui Yu, Joao G. Porto, Nachiketh Soodana Prakash, Adam Williams, Yuval Avda +21 more

Prognostic Significance of Immune Cell Infiltration in Muscle-invasive Bladder Cancer Treated with Definitive Chemoradiation: A Secondary Analysis of RTOG 0524 and RTOG 0712

European Urology Oncology(2024)10.1016/j.euo.2024.03.015

N/A

0DataRank · unranked

2 citations

Sophia C. Kamran, Amol C. Shetty, Philip Sutera, Yang Song, Soha Bazyar +29 more

Integrated framework for quantitative T2-weighted MRI analysis following prostate cancer radiotherapy

Physics and Imaging in Radiation Oncology(2024)10.1016/j.phro.2024.100660

N/A

0DataRank · unranked

2 citations

Adrian Breto, Ahmad Algohary, Veronica Wallaengen, Sandra M. Gaston, Sanoj Punnen +10 more

Radical prostatectomy cancer grade and percentage of Gleason pattern 4 estimated by global vs individual tumor grading correlate differently with the risk of biochemical recurrence in Grade Group 2 and 3 cancers

American Journal of Clinical Pathology(2024)10.1093/ajcp/aqae003

N/A

0DataRank · unranked

3 citations

Jonathan I. Epstein, Ali Merhe, Oleksii A. Iakymenko, R. Silva, Dimple Kumar Chanamolu +10 more

Predicting dose response to prostate cancer radiotherapy: validation of a radiation signature in the randomized phase III NRG/RTOG 0126 and SAKK 09/10 trials

Annals of Oncology(2025)10.1016/j.annonc.2025.01.017

N/A

0DataRank · unranked

16 citations

Pirus Ghadjar, Hyunnam Ryu, J.A. Proudfoot, Stefanie Hayoz, J.M. Michalski +28 more

Radiogenomic Profiling of Prostate Tumors prior to External Beam Radiotherapy Converges on a Transcriptomic Signature of TGF-β Activity Driving Tumor Recurrence

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-2186

N/A

0DataRank · unranked

2 citations

Uma Shankavaram, Shana Y. Trostel, Hong Zhang, Sumeyra Kartal, Houssein Abdul Sater +25 more

Decipher score as a predictor of response to treatment intensification in the NRG Oncology-RTOG 0534 (SPPORT) phase III randomized post-prostatectomy salvage radiotherapy trial.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.5_suppl.399

N/A

0DataRank · unranked

3 citations

Marla Johnson, J. Proudfoot, Elai Davicioni, Alan Dal Pra, Jeff Simko +15 more

Phase I Trial of MRI-Guided Prostate Cancer Lattice Extreme Ablative Dose (LEAD) Boost Radiation Therapy

International Journal of Radiation Oncology*Biology*Physics(2020)10.1016/j.ijrobp.2020.01.052

N/A

0DataRank · unranked

41 citations

Felix M. Chinea, Elizabeth Bossart, Deukwoo Kwon, Matthew C. Abramowitz, Charles M. Lynne +9 more

Integration of Habitat Risk Score in Radiation Therapy for Prostate Cancer

International Journal of Radiation Oncology*Biology*Physics(2025)10.1016/j.ijrobp.2025.09.074

N/A

0DataRank · unranked

0 citations

Adrian Breto, Ahmad Algohary, Veronica Wallaengen, Yiwei Jia, Sandra M. Gaston +10 more

Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifier

Prostate Cancer and Prostatic Diseases(2020)10.1038/s41391-020-0226-2

N/A

0DataRank · unranked

26 citations

Samuel R. Birer, R. Jeffrey Karnes, Jingbin Zhang, Elai Davicioni, Eric A. Klein +22 more

The Mutational Landscape of Metastatic Castration-sensitive Prostate Cancer: The Spectrum Theory Revisited

European Urology(2021)10.1016/j.eururo.2020.12.040

N/A

0DataRank · unranked

100 citations

Kim Van der Eecken, Ryan Phillips, Neil R. Parikh, Pedro Isaacsson Velho, Tamara L. Lotan +19 more

Novel genomic signature predictive of response to immune checkpoint blockade: A pan-cancer analysis from project Genomics Evidence Neo-plasia Information Exchange (GENIE)

Cancer Genetics(2021)10.1016/j.cancergen.2021.08.004

N/A

0DataRank · unranked

3 citations

William L. Hwang, Jimmy A. Guo, Hannah I. Hoffman, Matthew C. Abramowitz, Ziad El-Bakouny +24 more

Alan Pollack

Indexed papers

Top data-sharing exemplar

Papers